相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
Ko K. Maung et al.
BONE MARROW TRANSPLANTATION (2021)
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM
Thuja Meurer et al.
BLOOD (2021)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology
Geoffrey R. Hill et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis
Glen A. Kennedy et al.
BLOOD (2021)
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Benjamin Watkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease
Victor Tkachev et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
Margaret L. MacMillan et al.
BLOOD ADVANCES (2021)
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease
Andrea S. Henden et al.
BLOOD (2021)
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results
Joseph Pidala et al.
CLINICAL CANCER RESEARCH (2021)
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
Madan Jagasia et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
Lukas M. Braun et al.
HEMASPHERE (2021)
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Donna Przepiorka et al.
ONCOLOGIST (2020)
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups
Courtney M. Rowan et al.
BLOOD (2020)
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Abraham S. Kanate et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation
Nicholas J. Hess et al.
JOURNAL OF IMMUNOLOGY (2020)
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
Bruce R. Blazar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation
Saurabh Chhabra et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Cytokines and costimulation in acute graft-versus-host disease
Geoffrey R. Hill et al.
BLOOD (2020)
Deciphering site 3 interactions of interleukin 12 and interleukin 23 with their cognate murine and human receptors
Alessandra Esch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
Mark A. Schroeder et al.
BLOOD ADVANCES (2020)
Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
Sophia Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source
Nicholas J. Hess et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD
Eleonora Latis et al.
BLOOD ADVANCES (2020)
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant
Pingping Zheng et al.
BLOOD ADVANCES (2020)
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
Alex Ganetsky et al.
BONE MARROW TRANSPLANTATION (2019)
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice
Wendy W. Pang et al.
BLOOD (2019)
Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ
Luigi J. Alvarado et al.
BLOOD (2019)
Janus kinases to jakinibs: from basic insights to clinical practice
Massimo Gadina et al.
RHEUMATOLOGY (2019)
Hematopoietic chimerism and donor-specific skin allograft tolerance after non-genotoxic CD117 antibody-drug-conjugate conditioning in MHC-mismatched allotransplantation
Zhanzhuo Li et al.
NATURE COMMUNICATIONS (2019)
Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
Agnieszka Czechowicz et al.
NATURE COMMUNICATIONS (2019)
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota
Motoko Koyama et al.
IMMUNITY (2019)
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
Natalia S. Nunes et al.
FRONTIERS IN IMMUNOLOGY (2019)
Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice
Hye-Sook Kwon et al.
BLOOD (2019)
Mechanisms of immune escape after allogeneic hematopoietic cell transplantation
Robert Zeiser et al.
BLOOD (2019)
The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease
Motoko Koyama et al.
BLOOD (2019)
Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression
Michael A. Brehm et al.
FASEB JOURNAL (2019)
The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia
Amy K. Keating et al.
BLOOD ADVANCES (2019)
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K. Srinagesh et al.
BLOOD ADVANCES (2019)
In vivo dynamics of T cells and their interactions with dendritic cells in mouse cutaneous graft-versus-host disease
Sarah Morin-Zorman et al.
BLOOD ADVANCES (2019)
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
Govindarajan Thangavelu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia
Mark A. Schroeder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Bruce R. Blazar et al.
BLOOD (2018)
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
Hannah Major-Monfried et al.
BLOOD (2018)
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
William R. Drobyski et al.
HAEMATOLOGICA (2018)
Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials
Madan Jagasia et al.
IMMUNOTHERAPY (2018)
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
Brian C. Betts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
William R. Drobyski et al.
HAEMATOLOGICA (2018)
A Humanized Mouse Model Generated Using Surplus Neonatal Tissue
Matthew E. Brown et al.
STEM CELL REPORTS (2018)
Modeling Human Antitumor Responses In Vivo Using Umbilical Cord Blood-Engrafted Mice
Nicholas A. Zumwalde et al.
FRONTIERS IN IMMUNOLOGY (2018)
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
Gregory Ehx et al.
FRONTIERS IN IMMUNOLOGY (2018)
Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-lambda
Sophie Jacobs et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
Ying-Jun Chang et al.
FRONTIERS IN IMMUNOLOGY (2018)
A critical role for donor-derived IL-22 in cutaneous chronic GVHD
Kate H. Gartlan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation
Lori Muffly et al.
BLOOD ADVANCES (2018)
Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity
Xiaojing Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
Julius C. Fischer et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
MHC Bias by T Cell Receptors: Genetic Evidence for MHC and TCR Coevolution
Brian M. Baker et al.
TRENDS IN IMMUNOLOGY (2017)
Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Grafts-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
Aude Burlion et al.
FRONTIERS IN IMMUNOLOGY (2017)
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David Miklos et al.
BLOOD (2017)
Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome
Antiopi Varelias et al.
BLOOD (2017)
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Frederick L. Locke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment
Johnnie J. Orozco et al.
BLOOD (2016)
Cellular and molecular mechanisms in graft-versus-host disease
Lingling Zhang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10
B. Lamarthee et al.
MUCOSAL IMMUNOLOGY (2016)
Acute Graft-versus-Host Disease: Novel Biological Insights
Takanori Teshima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial
Carrie L. Kitko et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn et al.
BLOOD (2016)
How many TCR clonotypes does a body maintain?
Grant Lythe et al.
JOURNAL OF THEORETICAL BIOLOGY (2016)
Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
Rahul Palchaudhuri et al.
NATURE BIOTECHNOLOGY (2016)
Genetic variation in MHC proteins is associated with T cell receptor expression biases
Eilon Sharon et al.
NATURE GENETICS (2016)
Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3
Sonal Jangalwe et al.
IMMUNITY INFLAMMATION AND DISEASE (2016)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Yu Wang et al.
BLOOD (2015)
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts
Marie Bleakley et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nonirradiated NOD,B6.SCID Il2rγ-/- KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
Brian E. McIntosh et al.
STEM CELL REPORTS (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza et al.
BLOOD (2014)
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD
Christian M. Capitini et al.
BLOOD (2014)
IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation
Fan-ching Lin et al.
BLOOD (2014)
Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier
Kadriye Nehir Cosgun et al.
CELL STEM CELL (2014)
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Glen A. Kennedy et al.
LANCET ONCOLOGY (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
Alexandra Zanin-Zhorov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
Divya T. Koura et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease
Everett H. Meyer et al.
BLOOD (2013)
Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice
H. Sondergaard et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes
Sung W. Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease
C. Bossard et al.
LEUKEMIA (2012)
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease
Motoko Koyama et al.
NATURE MEDICINE (2012)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Type I-IFNs control GVHD and GVL responses after transplantation
Renee J. Robb et al.
BLOOD (2011)
Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice
Huihui Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Allo-HLA reactivity of virus-specific memory T cells is common
Avital L. Amir et al.
BLOOD (2010)
Bone marrow deficient in IFN-γ signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
Christian M. Capitini et al.
BLOOD (2009)
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex
M. A. King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
The molecular basis of TCR germline bias for MHC is surprisingly simple
K. Christopher Garcia et al.
NATURE IMMUNOLOGY (2009)
Hematopoietic stem cell transplantation without irradiation
Claudia Waskow et al.
NATURE METHODS (2009)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Benny J. Chen et al.
BLOOD (2007)
Molecular and functional evidence for activity of murine IL-7 on human lymphocytes
Joao T. Barata et al.
EXPERIMENTAL HEMATOLOGY (2006)
Activation-associated phenotype of CD3+ T cells in acute graft-versus-host disease
M. Paz Morante et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses
P Reddy et al.
NATURE MEDICINE (2005)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)
PA Taylor et al.
BLOOD (2005)
Cloning and expression of feline interleukin 15
GA Dean et al.
CYTOKINE (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
E Zino et al.
BLOOD (2004)
Transfer of aflogeneic CD62L- memory T cells without graft-versus-host disease
BJ Chen et al.
BLOOD (2004)
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
JH Antin et al.
BLOOD (2002)
V beta spectratype analysis reveals heterogeneity of CD4(+) T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: Correlations with epithelial tissue infiltrate
TM Friedman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
